MIRNA is a collaborative research network working across nine countries in sub-Saharan Africa and South Asia to strengthen maternal immunisation programmes in readiness for the introduction of new life-saving vaccines which will improve foetal and infant health.
Maternal vaccines protect mothers and infants from life-threatening infectious diseases during the most vulnerable stages of life.
A cross-institutional, cross-country consortium representing key regions in Africa and Asia.
Learn about the work MIRNA and others have been doing to support implementation of maternal vaccines
Subscribe to MIRNA's newsletter and follow updates to stay informed about the latest research and activities.
L’assemblée générale annuelle 2026 du consortium ODIN a réuni à Oxford des partenaires du consortium venus de toute l’Afrique et de l’Europe afin d’échanger sur les progrès accomplis, de partager ...
The 2026 ODIN Consortium’s Annual General Meeting brought together consortium partners from across Africa and Europe in Oxford to review progress, share lessons and agree priorities for the ODIN and ...
Digital mental health interventions for children are developing rapidly, yet a persistent gap remains between demonstrating that they work and making them available to families in routine care. This article ...
Findings from the Maternal Immunization Readiness Network in Africa and Asia (MIRNA) Partner Session, ICM Triennial Congress, Lisbon, 16 June 2026 Read more
The objective of the RPP is to leverage investments for advanced-stage clinical development of CEPI's portfolio vaccines and support countries in key regions to generate emergency evidence in future outbreaks Read more
SPEAC’s Special Populations team, in collaboration with Instituto de Efectividad Clínica y Sanitaria (IECS) and Tulane University, has launched an LSR and meta-analysis tool focused on the safety, effectiveness, and immunogenicity of Chikungunya vaccines Read more
